FindTrial
Sign In

A trial to study the place of surgery in elderly women with breast cancer treated by tamoxifen

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN72493595
Enrollment
Unknown
Registered
2001-07-01
Start date
1995-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Breast

Interventions

1. Group A: Optimal surgery plus tamoxifen, 20 mg twice daily 2. Group B: Tamoxifen, 20 mg twice daily All patients receive tamoxifen until there is evidence of progressive disease.

Sponsors

UK Co-ordinating Committee for Cancer Research (UKCCCR)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged >70 years 2. Histological, cytological or unequivocal mammographic confirmation of carcinoma of the breast 3. Operable breast cancer 4. No metastases 5. No previous malignancy, except skin cancer or adequately treated in situ carcinoma of the cervix 6. Fit and willing to receive either treatment

Exclusion criteria

Exclusion criteria: 1. Patients with bilateral breast cancer are excluded 2. Patients with Paget's disease without a palpable lump, in situ carcinoma or an impalpable lesion shown on mammograph alone are excluded

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026